Vidarbha News

Forecasted Obstructive Sleep Apnea Epidemiology covering the United States, EU5, and Japan 2030

 Breaking News
  • No posts were found

Forecasted Obstructive Sleep Apnea Epidemiology covering the United States, EU5, and Japan 2030

June 09
17:10 2021
Forecasted Obstructive Sleep Apnea Epidemiology covering the United States, EU5, and Japan 2030

Obstructive Sleep Apnea Epidemiology” report has been added to DelveInsight


Obstructive Sleep Apnea Overview

Obstructive Sleep Apnea Syndrome (OSA) is a clinical disorder marked by frequent pauses in breathing during sleep accompanied by loud noises.


Obstructive Sleep Apnea Epidemiology Forecast

DelveInsight’s ‘Obstructive Sleep Apnea (OSA) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Obstructive Sleep Apnea (OSA) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Request free sample copy-


Regions covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Obstructive Sleep Apnea Epidemiology Insights

OSA is subdivided into mild, moderate and severe OSA. According to the American Academy of Sleep Medicine (AASM), sleep that is interrupted five to 15 times per hour is defined as Mild Sleep Apnea; fifteen to 30 so-called “events” are rated as Moderate Sleep Apnea, and the presence of more than 30 events per night is classified as Severe Sleep Apnea.


Key facts of Obstructive Sleep Apnea epidemiology report

  • According to DelveInsight, the total prevalence of OSA in Adults was estimated at approximately 85.0 Million in 2017, for 7MM. The US alone accounts for approximately 47.00% of the prevalent adult cases, amongst the 7MM.
  • The estimates suggest the highest prevalence of Adult Obstructive Sleep Apnea (OSA) in the United States with approximately 40,032,300 cases in 2017.
  • In 7MM, men had higher prevalent cases of Obstructive Sleep Apnea as compared to women in 2017. This trend will continue and is expected to increase from 2017 to 2030.
  • Among the European countries, Germany had the highest adult prevalent population of Obstructive Sleep Apnea with approximately 8,556,400 cases, followed by the UK, which had a prevalent adult population of approximately 6,703,200 in 2017. On the other hand, Spain had the lowest adult prevalent population of approximately 5,248,200 cases in 2017.


Obstructive Sleep Apnea Epidemiology Segmentation in 7MM (2018–2030)

  • Total Prevalence
  • Total Prevalence of OSA by Age Group
  • Gender-specific Prevalence of OSA in Adults
  • Severity-specific Prevalence of OSA in Adults
  • Clinical Manifestations of OSA in Adults
  • Diagnosed cases of OSA in adults


Obstructive Sleep Apnea Epidemiology Perspective

The Obstructive Sleep Apnea (OSA) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Obstructive Sleep Apnea (OSA) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Obstructive Sleep Apnea (OSA) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Obstructive Sleep Apnea Epidemiology Report Scope

  • The Obstructive Sleep Apnea (OSA) report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis and treatment patterns
  • The Obstructive Sleep Apnea (OSA) Epidemiology Report and Model provide an overview of the risk factors and global trends of Obstructive Sleep Apnea (OSA) in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Obstructive Sleep Apnea (OSA) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Obstructive Sleep Apnea (OSA)
  • The report provides the segmentation of the Obstructive Sleep Apnea (OSA) epidemiology.


Request free sample copy-


Table of content

1. Key Insights

2. Executive Summary of Obstructive Sleep Apnea

3. SWOT Analysis for OSA

4. Disease Background and Overview

5. Epidemiology and Patient Population

6. 7MM Epidemiology

7. Treatment

8. Unmet Needs

9. Organizations contributing toward OSA

10. Case Study

11. Patient Journey

12. KOL Views

13. Appendix

14. DelveInsight Capabilities

15. Disclaimer

16. About DelveInsight


Obstructive Sleep Apnea Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population


Why should you buy this report?

  • Develop business strategies by understanding the trends shaping and driving the global Obstructive Sleep Apnea (OSA) market
  • Quantify patient populations in the global Obstructive Sleep Apnea (OSA) market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Obstructive Sleep Apnea (OSA) therapeutics in each of the markets covered
  • Understand the magnitude of Obstructive Sleep Apnea (OSA) population by its epidemiology
  • The Obstructive Sleep Apnea (OSA) Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources.


About DelveInsight

DelveInsight is a Business Consultant company and serves as a Knowledge Partner across the value chain of the Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios, and companies.


Contact Us 

Shruti Thakur

[email protected]


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States